In 2004, Jay’s group at Tufts University first reported the identification of a secreted protein from the conditioned medium of a fibrosarcoma cell line, HT-1080, and showed that the secreted protein promoted tumour cell invasion in vitro by activating the matrix metalloproteinase 2 (MMP2) [20]. The gene discussed is MMP2; the disease is fibrosarcoma.